[{"Assets_0_Q2_USD":807178000.0,"CommonStockSharesOutstanding_0_Q2_shares":49059644.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-161416000.0,"NetIncomeLoss_1_Q2_USD":-99681000.0,"NetIncomeLoss_2_Q2_USD":-187088000.0,"StockholdersEquity_0_Q2_USD":592827000.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]